Benchmark Third Quarter 2026 Earnings Call - BENCHMARK ELECTRONICS INC

Financial Performance:

• Q3 2026 revenue reached a record $811 million, up 19% year-over-year, surpassing the high end of guidance.
• Non-GAAP EPS was $0.84, representing a 35% year-over-year increase, nearly double the revenue growth rate.
• Non-GAAP gross margin improved 40 basis points to 10.5%, while non-GAAP operating margin expanded 70 basis points to 5.5% (30 bps sequentially).
• Operating cash flow was $30 million, with free cash flow of $14 million; capital expenditures were approximately $15 million.
• Balance sheet remains strong with $291 million in cash and $133 million in net debt; total borrowing capacity increased to $576 million following a $45 million revolver addition in Malaysia.
• Cash conversion cycle improved 23 days year-over-year to 54 days, reflecting disciplined working capital management.
• Full-year 2026 revenue guidance raised to exceed $3 billion, driven by 16% annual growth.

Guidance and Future Outlook:

• Q4 2026 revenue guidance set at $815 million to $855 million (19% YoY growth at midpoint).
• Q4 2026 non-GAAP EPS guidance raised to $0.85–$0.91; non-GAAP operating margin expected at 5.5%–5.7%.
• Full-year non-GAAP effective tax rate projected at 25%–26% due to initiatives structurally lowering the rate.
• Management targets earnings growth at 1.5x to 2x the rate of revenue growth for 2026 and into 2027.
• Capital expenditures expected to remain 2%–2.5% of revenue for the full year.
• Outlook assumes no contribution from next-generation HPC (AC&C) until mid-to-late 2027.
• Long-term visibility extends into 2029–2030, particularly within the semi-cap sector, with customers placing longer-term orders.

Business Segments and Product Lines:

• Semi-Cap: Revenue grew 30% YoY (8% sequentially), driven by strong industry demand and new program wins; expected to accelerate in Q4 and continue through 2027.
• Industrial: Revenue increased 13% YoY (7% sequentially), recovering from a Q2 revenue anomaly; new program awards and "lift-and-shift" contracts are driving growth.
• Medical: Revenue grew 9% YoY (3% sequentially); on pace for double-digit growth for the full year, aided by a significant new customer program (largest Q3 award).
• AC&C (Automotive, Communications, Consumer): Revenue surged 50% YoY (4% sequentially) driven by a major ramp; capacity expansion at PT4 Penang and future Thailand facility support this growth.
• Aerospace & Defense (A&D): Revenue down 1% YoY but up 15% sequentially; growth paused in 2026 due to program timing but expected to return in 2027 as new wins ramp.
• New Capacity: PT4 in Penang ramped successfully in July 2026; Thailand facility construction expected to complete in late 2027.

Market and Competitive Landscape:

• Semi-Cap: Industry narrative shifted from "recovery" to "durability," with customer visibility extending to 2029–2030.
• Competition: Benchmark is winning share due to disciplined go-to-market transformation and responsiveness to customer capacity needs during tight supply environments.
• Bookings: Healthy momentum across all sectors; Q3 bookings led by Medical, Industrial, and Semi-Cap, while A&D led in Q2.
• Supply Chain: Addressing shortages, particularly in ASIC and memory categories, through selective inventory investments and close collaboration with customers and suppliers.

Risks and Challenges:

• Supply Chain Constraints: Ongoing challenges in ASIC and memory supply chains require active management and potential inventory positioning.
• Capacity Headwinds: Margin efficiency in the short term may be impacted by capacity additions (e.g., PT4, Thailand) and variable compensation costs.
• Inventory Fluctuations: Inventory levels are rising sequentially (up ~16%) due to ramp preparation, though management targets long-term inventory turns of 5.0–5.5.
• Execution Risk: Delays in program ramps (e.g., HPC/AC&C) or supply chain disruptions could impact 2027 revenue realization.

Management Commentary and Tone:

• Tone: Highly confident and optimistic, emphasizing record revenue, earnings leverage, and broad-based demand improvement.
• Key Themes: Emphasized "durability" of the semi-cap upturn, successful execution of customer ramps, and the balance between growth investment and financial discipline.
• Strategic Focus: Continued commitment to organic growth, strategic capacity expansion, and maintaining operating leverage to drive bottom-line growth faster than top-line growth.

Analyst Questions and Answers:

• Growth Sustainability (David Williams, Needham): Management cited customer forecasts, ongoing global ramps, and deep customer conversations as drivers for 2027 confidence.
• Capacity Constraints: Confident current footprint (including new PT4) and future Thailand facility will meet demand through 2027 without bottlenecks.
• Margin Leverage (Stephen Fox, Fox Advisors): Expects continued gross margin efficiency into 2027 as new capacity fills, partially offset by variable comp headwinds and mix factors.
• AC&C & HPC Timing (Max Michaelis, Lake Street): HPC opportunities are layered on existing AC&C work but shifted slightly later than previously stated, now expected mid-to-late 2027.
• Supply Chain Visibility: Customers are placing longer orders for 2029–2030, creating a more stable demand environment than historical norms.
• Medical Outlook (Anja Soderstrom, Sedoti): Sector bottomed in summer 2025; new program wins and ramps suggest potential for sustained growth through 2028.
• Inventory Management: Inventory build is strictly tied to supporting active program ramps at 11 global sites, not speculative stocking.

Other Key Points:

• Benchmark will ring the closing bell at the NYSE on November 3rd to celebrate its 30th anniversary as a public company.
• Management highlighted a record number of new customer wins and the breadth of growth across the portfolio compared to previous years.
• Shareholder returns included $14 million in dividends and share repurchases during Q3.
• The company is actively managing a balanced portfolio where different sectors lead growth cycles, reducing reliance on any single market.